Jyong Biotech MENS
NASDAQ MENS
$1.79 +0.05 (+2.88%)
As of: Oct 23, 2026 · 2:16 PM EDT

Jyong Biotech (MENS) Assets (2024 - 2025)

Updated

Jyong Biotech's Assets was $20.78 million in the quarter ended Dec 31, 2025, up 226.4% from $6.37 million a year earlier.

Analysis

Jyong Biotech (MENS) Assets (2024 - 2025) Analysis & Trends

  • In earlier years, Assets was $6.37 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn 197.43 Bn
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn 135.12 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn 115.83 Bn
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 201.13 Bn
10 Jyong Biotech 129.96 Mn 129.96 Mn - 20.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.78 Mn
Jun 30, 2025 37.67 Mn
Dec 31, 2024 6.37 Mn
API Access

Jyong Biotech Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=MENS&period=max&api_key=YOUR_API_KEY